Virginia Retirement Systems ET AL Takes $11.24 Million Position in Thermo Fisher Scientific Inc. (TMO)

Virginia Retirement Systems ET AL purchased a new stake in shares of Thermo Fisher Scientific Inc. (NYSE:TMO) in the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm purchased 59,400 shares of the medical research company’s stock, valued at approximately $11,238,000.

Several other hedge funds have also added to or reduced their stakes in the company. Covington Capital Management raised its stake in shares of Thermo Fisher Scientific by 0.9% during the second quarter. Covington Capital Management now owns 2,144 shares of the medical research company’s stock valued at $374,000 after acquiring an additional 20 shares during the last quarter. Investment Centers of America Inc. raised its stake in shares of Thermo Fisher Scientific by 1.6% during the second quarter. Investment Centers of America Inc. now owns 1,317 shares of the medical research company’s stock valued at $230,000 after acquiring an additional 21 shares during the last quarter. Fort Washington Investment Advisors Inc. OH raised its stake in shares of Thermo Fisher Scientific by 0.4% during the second quarter. Fort Washington Investment Advisors Inc. OH now owns 6,250 shares of the medical research company’s stock valued at $1,090,000 after acquiring an additional 23 shares during the last quarter. Bienville Capital Management LLC raised its stake in shares of Thermo Fisher Scientific by 1.6% during the second quarter. Bienville Capital Management LLC now owns 1,687 shares of the medical research company’s stock valued at $295,000 after acquiring an additional 27 shares during the last quarter. Finally, Savant Capital LLC raised its stake in shares of Thermo Fisher Scientific by 1.0% during the second quarter. Savant Capital LLC now owns 2,793 shares of the medical research company’s stock valued at $487,000 after acquiring an additional 29 shares during the last quarter. 86.16% of the stock is owned by hedge funds and other institutional investors.

In other Thermo Fisher Scientific news, CEO Marc N. Casper sold 50,000 shares of Thermo Fisher Scientific stock in a transaction on Wednesday, November 15th. The shares were sold at an average price of $188.39, for a total value of $9,419,500.00. Following the completion of the sale, the chief executive officer now directly owns 252,577 shares of the company’s stock, valued at $47,582,981.03. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. Insiders own 0.49% of the company’s stock.

Thermo Fisher Scientific Inc. (TMO) remained flat at $$189.49 on Wednesday. 1,301,400 shares of the company’s stock were exchanged, compared to its average volume of 1,563,304. Thermo Fisher Scientific Inc. has a 52 week low of $139.88 and a 52 week high of $201.20. The company has a quick ratio of 0.81, a current ratio of 1.26 and a debt-to-equity ratio of 0.85. The stock has a market capitalization of $75,984.62, a P/E ratio of 20.82, a P/E/G ratio of 1.74 and a beta of 1.06.

Thermo Fisher Scientific (NYSE:TMO) last posted its quarterly earnings results on Wednesday, October 25th. The medical research company reported $2.31 earnings per share for the quarter, beating the consensus estimate of $2.24 by $0.07. Thermo Fisher Scientific had a net margin of 11.73% and a return on equity of 15.94%. The firm had revenue of $5.12 billion during the quarter, compared to the consensus estimate of $5.03 billion. During the same period in the previous year, the firm posted $2.03 earnings per share. The business’s revenue was up 13.9% compared to the same quarter last year. equities research analysts expect that Thermo Fisher Scientific Inc. will post 9.36 earnings per share for the current year.

The business also recently declared a quarterly dividend, which will be paid on Monday, January 15th. Shareholders of record on Friday, December 15th will be paid a $0.15 dividend. This represents a $0.60 annualized dividend and a yield of 0.32%. The ex-dividend date is Thursday, December 14th. Thermo Fisher Scientific’s dividend payout ratio (DPR) is currently 10.19%.

TMO has been the subject of several analyst reports. Cowen reaffirmed a “buy” rating and set a $200.00 price target on shares of Thermo Fisher Scientific in a research note on Friday, September 1st. Argus reissued a “buy” rating on shares of Thermo Fisher Scientific in a research note on Tuesday, August 22nd. They noted that the move was a valuation call. Zacks Investment Research raised shares of Thermo Fisher Scientific from a “hold” rating to a “buy” rating and set a $208.00 target price for the company in a research note on Thursday, September 7th. Goldman Sachs Group initiated coverage on shares of Thermo Fisher Scientific in a research note on Tuesday, September 26th. They set a “buy” rating and a $225.00 target price for the company. Finally, Deutsche Bank set a $226.00 target price on shares of Thermo Fisher Scientific and gave the stock a “buy” rating in a research note on Thursday, October 26th. One investment analyst has rated the stock with a hold rating and sixteen have assigned a buy rating to the company. Thermo Fisher Scientific presently has an average rating of “Buy” and a consensus target price of $205.21.

COPYRIGHT VIOLATION NOTICE: “Virginia Retirement Systems ET AL Takes $11.24 Million Position in Thermo Fisher Scientific Inc. (TMO)” was published by StockNewsTimes and is the property of of StockNewsTimes. If you are reading this story on another site, it was stolen and republished in violation of United States and international copyright and trademark legislation. The legal version of this story can be viewed at https://stocknewstimes.com/2017/12/13/virginia-retirement-systems-et-al-takes-11-24-million-position-in-thermo-fisher-scientific-inc-tmo.html.

Thermo Fisher Scientific Profile

Thermo Fisher Scientific Inc develops, manufactures and sells a range of products. The Company provides analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.

Want to see what other hedge funds are holding TMO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Thermo Fisher Scientific Inc. (NYSE:TMO).

Institutional Ownership by Quarter for Thermo Fisher Scientific (NYSE:TMO)

Receive News & Ratings for Thermo Fisher Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply